GE’s SPECT System Gets FDA Clearance

Article

GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance.

GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance, the company announced.

The Brivo NM615, designed as a cost-effective way to perform routine scanning while expanding their capabilities, allows doctors to lower injected patient dose by up to 50 percent of those of standard nuclear medicine scanning protocols, or the potential for patients to spend less time on the exam table, without compromising image quality, according to the company.

The system has a 70 cm wide bore and table capable of handling patients up to 500 pounds. The Brivo NM 615 can also be upgraded on site to the GE Healthcare Discover NM630 or the Discovery NM/CT 670 SPECT/CT hybrid systems. As a result, the system may expand the capability to serve patients in the future at faster speeds and with SPECT/CT hybrid scans.

Brivo NM615 can be used with the advanced Xeleris workstation, which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices.

 

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.